Burning Rock Biotech Ltd (BNR)
About Burning Rock Biotech Ltd
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $77.2M
- Net income
- -$7.9M
- Total assets
- $117.3M
- Market cap
- $97.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $97.1M
- Shares outstanding
- 10.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 12, 2020
Burning Rock Biotech Ltd (BNR) Stock Price
- Reported a net loss of $7.9M in FY2025.
- Trading 78% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Burning Rock Biotech Ltd.
Write a review
News about Burning Rock Biotech Ltd
News & sentiment via Polygon.io
Burning Rock Biotech Ltd: frequently asked questions
Is Burning Rock Biotech Ltd an American company?
Burning Rock Biotech Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Burning Rock Biotech Ltd publicly traded?
Yes — Burning Rock Biotech Ltd is a publicly traded company. Its stock trades under the ticker symbol BNR on the NASDAQ.
What does Burning Rock Biotech Ltd do?
Burning Rock Biotech Ltd is an American Medical Devices company in the Health & Beauty sector.
